The Next Step of Their Control Is Here …

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

Gregory Harper Biography and Net Worth

VP of Neuronetics

Gregory Harper serves as Vice President - Product Development and Operations of the Company. Prior to joining our company, Mr. Harper was the Vice President, CT Global Research and Development for the Philips Healthcare Computed Tomography from March 2015 to September 2016, where he was responsible for leading the product innovation pipeline and development activities. From January of 2011 to March 2015, Mr. Harper held roles as Director, Computed Tomography Performance and Senior Director, Computed Tomography and Nuclear Medicine within Philips Healthcare. Prior to Philips, Mr. Harper worked in General Electric in the Healthcare, Lighting and Appliance, and Aerospace businesses. Mr. Harper earned his BSEE from Valparaiso University and his MBA from the University of Wisconsin, Milwaukee.

What is Gregory Harper's net worth?: The estimated net worth of Gregory Harper is at least $567,313.46 as of March 9th, 2021. Mr. Harper owns 162,554 shares of Neuronetics stock worth more than $567,313 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Harper may own. Learn More about Gregory Harper's net worth.
How do I contact Gregory Harper?: The corporate mailing address for Mr. Harper and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected]. Learn More on Gregory Harper's contact information.
Has Gregory Harper been buying or selling shares of Neuronetics?: Gregory Harper has not been actively trading shares of Neuronetics during the last ninety days. Most recently, Gregory Harper sold 5,524 shares of the business's stock in a transaction on Tuesday, March 9th. The shares were sold at an average price of $14.65, for a transaction totalling $80,926.60. Following the completion of the sale, the vice president now directly owns 162,554 shares of the company's stock, valued at $2,381,416.10. Learn More on Gregory Harper's trading history.
Who are Neuronetics' active insiders?: Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.
Are insiders buying or selling shares of Neuronetics?: In the last twelve months, insiders at the sold shares 17 times. They sold a total of 202,262 shares worth more than $610,676.94. The most recent insider tranaction occured on February, 28th when EVP William Andrew Macan sold 22,377 shares worth more than $70,711.32. Insiders at Neuronetics own 9.8% of the company. Learn More about insider trades at Neuronetics.
Information on this page was last updated on 2/28/2024.

Gregory Harper Insider Trading History at Neuronetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2021	Sell	5,524	$14.65	$80,926.60	162,554
1/21/2021	Sell	2,969	$18.21	$54,065.49	150,993
12/16/2019	Buy	10,000	$4.40	$44,000.00	75,480

Gregory Harper Buying and Selling Activity at Neuronetics

Neuronetics Company Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $3.49

$3.35

$3.55

50 Day Range

MA: $3.92

$2.79

$4.81

2 Week Range

Now: $3.49

$1.03

$5.07

Volume

44,572 shs

Average Volume

180,264 shs

Market Capitalization

$104.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.44